Higher expression of MCT4 and CA-IX was previously found in poorly differentiated and anaplastic thyroid carcinoma as compared to PTC and FTC and in FTC as compared to FA [18, 19]. The gene discussed is SLC16A4; the disease is thyroid cancer, nonmedullary, 2.